Auxier Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Auxier Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24,172	Closed	-$1.3M	–	153
2017 Q4	$1.3M	Buy	24,172 +5	+0%	+$274	0.25%	88
2017 Q3	$1.38M	Sell	24,167 -12	-0%	-$703	0.28%	82
2017 Q2	$1.46M	Hold	24,179	–	–	0.3%	83
2017 Q1	$1.32M	Buy	+24,179	New	+$1.19M	0.28%	84

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Auxier Asset Management's BIVV Position: Q1 2018 in Review

Auxier Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 24,172 shares — an estimated $1.3M sold.

Auxier Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.46M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Auxier Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Auxier Asset Management sold 24,172 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.3M.
Auxier Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Auxier Asset Management's Bioverativ Inc. Common Stock position peaked at $1.46M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Auxier Asset Management's 13F filing for Q1 2018, filed 14 May 2018.